Elizabeth Liles

Ms. Elizabeth Liles

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
Mohammad HaddadiMohammad Haddadi
Mohammad Haddadi
NRNeha Raghuraman
Neha Raghuraman
ELElizabeth Liles
Elizabeth Liles
nimesha prashadininimesha prashadini
nimesha prashadini
SHSam Halabi
Sam Halabi
Introduction: Surrogacy is a rapidly evolving area of reproductive health that spans ethical, legal, clinical, and societal dimensions. Policies governing surrogacy vary widely across countries, shaping access to services, safeguarding measures, and the protection of women and children. While some nations permit regulated altruistic or commercial surrogacy, others impose outright bans, creating global disparities and driving reproductive travel. This review examined publicly available surrogacy policies and guidance, with a focus on commissioning decisions, operational processes, and international cross-border complexities. Methods: Following PRISMA guidelines, a systematic search publicly accessible English-language surrogacy policies and guidance documents were identified through a comprehensive search of health service commissioning bodies, government agencies, and professional organisations. Thematic analysis was conducted to explore policy scope, legal frameworks, safeguarding procedures, and international variation. Policies were then compared to assess areas of convergence and divergence across global settings. Results: Globally, surrogacy regulation is highly fragmented. In Europe, most countries prohibit commercial surrogacy and, in some cases, altruistic arrangements, while nations such as the UK, Ireland, and Greece allow tightly controlled altruistic surrogacy. North America shows a patchwork approach, with some US states and Canada permitting altruistic or compensated arrangements under varying levels of regulation. In Asia, historical hubs such as India and Thailand have shifted from permissive commercial surrogacy to restrictive altruistic-only models following concerns over exploitation. Africa remains largely unregulated, except for South Africa’s comprehensive legal framework. Across settings, recurrent themes included safeguarding concerns, ethical debates over exploitation versus autonomy, and challenges in determining legal parentage and nationality. Cross-border arrangements amplify these complexities, often leaving children stateless or without clear legal protections. Conclusion: The absence of harmonised frameworks perpetuates inequities in women’s health and cross-border surrogacy, often exposing individuals to financial, legal, and health risks. These challenges underscore the urgent need for evidence-based policies and fairer, more equitable approaches to surrogacy.

10 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
nimesha prashadininimesha prashadini
nimesha prashadini
NRNeha Raghuraman
Neha Raghuraman
Mohammad HaddadiMohammad Haddadi
Mohammad Haddadi
ELElizabeth Liles
Elizabeth Liles
Abirame SivakumarAbirame Sivakumar
Abirame Sivakumar
GDGayathri Delanerolle
Gayathri Delanerolle
Background: Women in perimenopause, menopause, and post-menopause experience significant biological, psychological, and social changes, including vasomotor symptoms, urogenital atrophy, sleep disturbances, and cognitive shifts. Despite the impact on quality of life, productivity, and social participation, these life stages are underrepresented in national and international health policies compared to reproductive years.Methods: A systematic review following PRISMA guidelines was conducted. English-language national and international policy documents published up to March 2025 were retrieved from PubMed, Science Direct, Google Scholar, WHO, UNFPA, and national health ministry websites. Policies were included if they addressed women’s health during perimenopause, menopause, or post-menopause. Data extraction captured policy focus, target populations, chronic disease management, cancer screening, menopause care, equity considerations, and alignment with global standards. Thematic and conceptual analyses synthesized findings into key domains and gaps.Results: Thirty policies from 13 jurisdictions were reviewed, addressing women’s health across the reproductive life course, including peri-menopause, menopause, and post-menopause. Common priorities included chronic disease management, menopause symptom management, cancer prevention and screening, mental health support, and management of reproductive disorders such as PCOS, endometriosis, and infertility. Equity considerations focused on underserved populations, including rural women, socioeconomically disadvantaged groups, Indigenous and ethnic minorities, and other high-risk populations such as sex workers and adolescents. Conclusion: Policies addressing later reproductive years remain heterogeneous, with inconsistent integration of chronic disease management, cancer screening, and reproductive health care. Strengthening equitable, evidence-based policy frameworks is crucial to support women’s health, reduce disparities, and improve quality of life during perimenopause, menopause, and post-menopause.

10 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
Mohammad HaddadiMohammad Haddadi
Mohammad Haddadi
NRNeha Raghuraman
Neha Raghuraman
ELElizabeth Liles
Elizabeth Liles
nimesha prashadininimesha prashadini
nimesha prashadini
SHSam Halabi
Sam Halabi
Introduction: In vitro fertilisation (IVF) has become an integral component of reproductive health, enabling millions of individuals, couples, and others to achieve intended, non-adoptive parenthood. However, governance of IVF remains highly variable, shaped by statutory law, religion, culture, and resource allocation. While some countries have developed robust statutory frameworks, others rely on interim codes or fragmented commissioning policies, creating inequities in access, safety, and inclusivity. Methods: A systematic methodology was developed in accordance with the PRISMA guidelines to examine IVF policies published across the United Kingdom (UK) and the continents of Asia, Africa, Europe, Oceania and South America. All policy documents available in a digital format from 20th of August 1990, to 2025 were included. National policies, laws, and regional commissioning frameworks explicitly addressing IVF policies were also included. Data extraction captured the statutory basis, eligibility criteria, financing models, clinical standards, and ethical provisions. A thematic, contextual and comparative analysis was conducted, complemented by descriptive statistics summarising age limits, body mass index (BMI) thresholds, inclusivity, and financing arrangements. Results: Analysis revealed wide heterogeneity in IVF policies. Marital restrictions in Iran, the Maldives, China, and Texas excluded single and LGBTQIA+ individuals, whereas South Africa, Wales, Montana, and Oregon guaranteed inclusivity. Public funding was comprehensive in South Korea and Wales but limited in Oman, Jersey, and several U.S. states. Clinical standards such as single embryo transfer were common, yet policies on gamete donation, storage, and consent varied substantially, undermining equity. Conclusion: IVF policy globally remains fragmented, reflecting divergent intersections of law, religion, and resource allocation. Statutory anchors and inclusive financing models support safety and access, yet restrictive eligibility criteria and fragmented commissioning perpetuate inequity. Regulation informed by equity and inclusivity factors, as well as integration into reproductive health strategies, is needed to ensure equitable and universal access to IVF.

21 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Mohammad HaddadiMohammad Haddadi
Mohammad Haddadi
NRNeha Raghuraman
Neha Raghuraman
GDGayathri Delanerolle
Gayathri Delanerolle
ELElizabeth Liles
Elizabeth Liles
PPPeter Phiri
Peter Phiri
SHSam Halabi
Sam Halabi
Background Human intervention to terminate a pregnancy, while medically effected through a range of pharmaceutical, surgical, and other approaches, is generally referred to in English as “abortion.” It is a fundamental aspect of reproductive healthcare and its availability, regulation, and limits (cultural, familial, legal) are well-documented determinants of women’s and girls’ health worldwide. Despite its routine nature in many health systems, it remains a deeply sensitive issue shaped by cultural, legal, religious, and political factors. Globally, an estimated 73 million abortions occur annually, yet access to safe and timely care is highly variable. In settings where abortion is legal and integrated into healthcare services, it is one of the safest medical procedures. Conversely, restrictive policies force individuals to seek unsafe alternatives, contributing to preventable maternal deaths and long-term health complications. Laws and regulations play a pivotal role in shaping access, but these are influenced by societal norms and often create inequities within and between countries. Methods A systematic review was conducted to identify, collate, and analyse publicly available abortion policies and legislation in English from 1980 to 2025. Data sources included peer-reviewed literature, legal databases, national government portals, and grey literature from global health organisations. Policies were screened, extracted, and appraised using a structured framework. A thematic and contextual analysis was undertaken to explore the legal, operational, and governance components of abortion policies and their implications for access and equity. ResultsPolicies from over 100 countries were included, demonstrating significant global variation. Liberal frameworks, such as those in Iceland, Sweden, England, and New Zealand, were associated with early, safe access through broad on-demand gestational limits and integrated care. Restrictive or grounds-based models, common in parts of Eastern Europe, the Middle East, and Latin America, relied on multi-clinician approvals, waiting periods, and documentation, creating delays and inequities. Federated systems, including the United States and Australia, showed marked regional disparities. Criminal penalties in several countries had a chilling effect, driving cross-border travel and unsafe abortion. Conclusion Global abortion policies vary widely, with many failing to translate legal rights into equitable, practical access. Evidence-informed reforms that integrate health systems research and cultural context are urgently needed to reduce preventable harm and promote reproductive justice.

15 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
Mohammad HaddadiMohammad Haddadi
Mohammad Haddadi
NRNeha Raghuraman
Neha Raghuraman
ELElizabeth Liles
Elizabeth Liles
nimesha prashadininimesha prashadini
nimesha prashadini
SHSam Halabi
Sam Halabi
Background: Abortion is a core component of reproductive healthcare and a critical determinant of maternal health outcomes. Globally, approximately 73 million abortions occur annually, with unsafe abortion contributing to 4.7–13.2% of maternal deaths, primarily in low- and middle-income countries (LMICs). Legal frameworks governing abortion vary widely, ranging from total prohibition to fully integrated care systems. Access is further shaped by health system capacity, procedural barriers, and socio-economic inequities. In an increasingly globalised world, migration adds complexity, as individuals move between countries with differing policies, influencing both direct access to care and regional healthcare dynamics. Understanding these intersecting factors is essential for improving reproductive health equity and reducing preventable morbidity and mortality. Methods: A global comparative analysis was conducted using two integrated datasets covering 100 countries. The first dataset captured legal, operational, and contextual variables, including gestational limits, funding mechanisms, provider cadres, and telemedicine availability. The second dataset provided demographic, socio-economic, and health system indicators. Access Scores were derived from weighted indicators on a 0–10 scale. Analyses included descriptive statistics, bivariate associations, and multivariable ordinal logistic regression. An intersectional approach explored disparities across income groups, geographic regions, and migration pathways, with visualisation tools such as heatmaps, bubble plots, and diaspora exposure differentials. Results: Countries with telemedicine-enabled early medical abortion (tele-EMA) were significantly associated with higher Access Scores (OR ≈1.45), while each additional mandated waiting day reduced odds of liberal access by 7%. Mid-level provider authorisation and public funding alone did not predict improved access. Migration analysis revealed that LMIC-to-HIC flows resulted in marked improvements in abortion access, though benefits were unevenly distributed, leaving vulnerable populations behind. African and Asian LMICs had the lowest Access Scores, reflecting systemic underfunding and restrictive laws. Conclusion: Abortion access is shaped by functional health system design rather than geography alone. Removing procedural barriers, expanding telemedicine, and embedding services within integrated health systems are essential to achieving equitable, sustainable reproductive healthcare worldwide.

10 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NRNeha Raghuraman
Neha Raghuraman
Mohammad HaddadiMohammad Haddadi
Mohammad Haddadi
ELElizabeth Liles
Elizabeth Liles
nimesha prashadininimesha prashadini
nimesha prashadini
Abirame SivakumarAbirame Sivakumar
Abirame Sivakumar
GDGayathri Delanerolle
Gayathri Delanerolle
Background: Adolescents and young women represent a critical population in global health policy, yet their needs are often subsumed under broader maternal health agendas. While international frameworks such as CEDAW, the ICPD Programme of Action, the Beijing Platform for Action, and the Sustainable Development Goals have emphasized equity and rights, their translation into adolescent- and youth-sensitive policy remains inconsistent. Methods: We conducted a systematic review of 48 national and international women’s health policies and frameworks published from the 1990s to 2020s, following PRISMA 2020 guidelines. Documents were mapped for contextual features and thematically analyzed to identify patterns in financing, service delivery, equity, and adolescent/youth health priorities. Results: Policies reflected an evolution from maternal survival toward rights-based and life-course approaches, shaped by global frameworks. High-income countries integrated equity and adolescent rights more explicitly, while low- and middle-income countries were constrained by donor-driven priorities and limited fiscal space. Across contexts, adolescents and young women were inconsistently prioritized—acknowledged in some cases (e.g., Sri Lanka, Ghana, Australia) but rarely operationalized into enforceable protections, dedicated financing, or adolescent-friendly services. Persistent barriers included hidden costs, stigma, confidentiality gaps, and weak accountability mechanisms. Conclusion: Despite progress in global commitments, adolescents and young women remain underrepresented and underserved in health policies, in part because their health needs are not sufficiently distinguished. Strengthening adolescent health requires enforceable entitlements, ring-fenced financing, youth-friendly service standards, and participatory governance. Without these measures, policies risk remaining symbolic rather than transformative, leaving adolescents vulnerable to preventable health risks and inequities.